Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This registry aims to monitor the safety of Breviscapine Powder-Injection and to identify the potential risk factors for the adverse drug reactions.
Breviscapine Powder-Injection is a kind of natural compound injection with high purity of Scutellarin-Na (over 98%). It's a popular drug for ischemic diseases, as cerebral ischemic stroke, coronary heart disease or angor pectoris. However, more and more case reports about the adverse drug events of Chinese medicine injections extracted from Dengzhanhua (herba erigernotis) (Breviscapine is one of the most common compounds in it) have been reported in recent 10 years. Therefore, this registry of Breviscapine Powder-Injection aims to monitor the safety of Breviscapine Powder-Injection and to identify the potential risk factors for the adverse drug reactions.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Breviscapine Powder-Injection | Breviscapine Powder-Injection will be given to the patients, and the investigators will record all the information including ADR, application of Breviscapine Powder-Injection and the combined medications, etc. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Breviscapine Powder-Injection | Drug | Patients will be given Breviscapine Powder-Injection according to their disease condition in the real world. The investigator only can record the information on the usage of the drug and the relevant medications without any interventions. |
| Measure | Description | Time Frame |
|---|---|---|
| The incidence of anaphylactic reaction to Breviscapine Powder-Injection | 1 years |
| Measure | Description | Time Frame |
|---|---|---|
| The incidence of severe adverse events (SAEs) to Breviscapine Powder-Injection | 1 years | |
| The incidence of new SAEs to Breviscapine Powder-Injection | 1 years | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients who use Breviscapine Powder-Injection in the monitoring departments of centain hospitals
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zhong Wang, M.D. | China Academy of Chinese Medical Sciences | Study Director |
| Xin-zhi Wang | The First Hospital of Henan College of Traditional Chinese Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing Municipality | 400010 | China | ||
Not provided
Not provided
Not provided
Not provided
|
| The incidence of adverse drug events (ADEs) to Breviscapine Powder-Injection |
| 1 years |
| The incidence of new ADEs to Breviscapine Powder-Injection | 1 years |
| The effective rate of Breviscapine Powder-Injection | The proportion of the patients whose drug effect is considered as "effective" by investigator. | 1 years |
| The patient satisfaction rate for the therapy of Breviscapine Powder-Injection | 1 years |
| The People's Hospital of Zuanjiang District, Chongqing City |
| Chongqing |
| Chongqing Municipality |
| 401420 |
| China |
| Mudanjiang City Second People's Hospital | Mudanjiang | Heilongjiang | 157013 | China |
| People's Hospital of Jun County | Hebi | Henan | 456250 | China |
| People's Hospital of Changge City | Xuchang | Henan | 461599 | China |
| The Second Affiliated Hospital of Zhengzhou University | Zhengzhou | Henan | 450014 | China |
| Zhengzhou Second Hospital | Zhengzhou | Henan | 450015 | China |
| The First Hospital of Henan College of Traditional Chinese Medicine | Zhengzhou | Henan | 451199 | China |
| Zaozhuang Hospital of T.C.M | Zaozhuang | Shandong | 277000 | China |
| Shandong Energy Zaozhuang Mining Group Center Hospital | Zaozhuang | Shandong | 277800 | China |
| Shanxi Provincial Hospital of Traditional Chinese Medicine | Taiyuan | Shanxi | 030012 | China |
| Changzheng Hospital of Tianjin City | Tianjin | Tianjin Municipality | 300021 | China |
| Tianjin Medical University General Hospital | Tianjin | Tianjin Municipality | 300052 | China |
| The Red Cross Hosptal of Yunnan | Kunming | Yunnan | 650021 | China |
| First Affilicated Hospital of Kunming Medical University | Kunming | Yunnan | 650032 | China |
| ID | Term |
|---|---|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
| D000707 | Anaphylaxis |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided